Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute thioproline poisoning

R Garnier, M L Efthymiou, E Fournier

    Journal of Toxicology. Clinical Toxicology
    |May 1, 1982
    PubMed
    Summary

    Thiazolidine-4-carboxylic acid (A.T.C.), used for liver and biliary issues, may cause convulsions in children. Recent research suggests A.T.C. could treat epidermoid carcinoma, necessitating a risk-benefit evaluation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Carpal tunnel syndrome: Rare causes and associated forms behind a common and stereotyped affection].

    La Revue de medecine interne·2020
    Same author

    Immature platelet fraction (IPF): A reliable tool to predict peripheral thrombocytopenia.

    Current research in translational medicine·2019
    Same author

    Fungal adaptation to contemporary fungicide applications: the case of Botrytis cinerea populations from Champagne vineyards (France).

    Molecular ecology·2017
    Same author

    Phenotypic spectrum of Charcot-Marie-Tooth disease due to LITAF/SIMPLE mutations: a study of 18 patients.

    European journal of neurology·2017
    Same author

    Exposure of bovine oocytes and embryos to elevated non-esterified fatty acid concentrations: integration of epigenetic and transcriptomic signatures in resultant blastocysts.

    BMC genomics·2016
    Same author

    [One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG].

    Revue de pneumologie clinique·2016

    Area of Science:

    • Pharmacology
    • Oncology
    • Hepatology

    Background:

    • Thiazolidine-4-carboxylic acid (A.T.C.) has been available since 1964 for hepatic and biliary disorders.
    • The drug's toxicity, particularly convulsions in children due to overdosage, was noted by poison control centers in 1970.
    • Recent investigations propose A.T.C. for epidermoid carcinoma treatment, citing potential reverse transformation of tumor cells.

    Purpose of the Study:

    • To evaluate the therapeutic risk of Thiazolidine-4-carboxylic acid (A.T.C.).
    • To clarify the safety profile of A.T.C. in light of potential new applications.
    • To assess the balance between the benefits and risks of A.T.C. for hepatic, biliary, and oncological indications.

    Main Methods:

    • Review of historical clinical data regarding A.T.C. toxicity.
    • Analysis of recent research on A.T.C.'s efficacy in epidermoid carcinoma.
    • Pharmacological assessment of A.T.C.'s mechanism of action on tumor cells.

    Main Results:

    • Established toxicity of A.T.C. including convulsions in pediatric overdosage cases.
    • Emerging evidence suggests A.T.C. may induce reverse transformation of epidermoid carcinoma cells.
    • Potential for widespread use of A.T.C. if anticancer efficacy is confirmed.

    Conclusions:

    • The established toxicity of A.T.C. requires careful consideration.
    • Further research is essential to confirm the efficacy and safety of A.T.C. in cancer treatment.
    • A comprehensive risk-benefit analysis is crucial before widespread adoption of A.T.C. for new indications.

    Related Experiment Videos